Menopause and cardiovascular risk;Ménopause et risque cardiovasculaire

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 41, Issue 7 SUPPL., 2012, Pages

  Dessapt, A L ^a   Gourdy, P ^b  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b Université de Toulouse   (France)

Author keywords

Atheroma; Cardiovascular risk; Estrogens; Hormonal replacement therapy (HRT); Menopause

Indexed keywords

EID: 84868197834     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2012.09.003     Document Type: Short Survey

References (31)

1. es Journées nationales, Paris 2010. (Cinquième partie : la ménopause).
2. S. Yusuf, S. Hawken, and S. Ounpuu Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the Interheart study): case-control study Lancet 364 2004 937 952
3. M. Seed, and R.H. Knopp Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placeo-cintrolled trials of hormone-replacement therapy Curr Opin Lipidol 15 2004 459 467
4. B.W. Walsh, I. Schiff, B. Rosner, L. Greenberg, V. Ravnikar, and F.M. Sacks Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins N Engl Med 325 1991 1196 1204
5. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc Res 53 2002 605 619
6. J.F. Arnal, P.Y. Scarabin, F. Tremollieres, H. Laurell, and P. Gourdy Estrogens in vascular biology and disease: where do we stand today? Curr Opin Lipidol 18 2007 554 560
7. D. Grady, D. Herrington, V. Bittner, R. Blumenthal, M. Davidson, and M. Hlatky Cardiovacsular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogens/progestin Replacement Study follow-up (HERS II) JAMA 288 2002 49 57
8. J.E. Manson, J. Hsia, K.C. Johnson, J.E. Rossouw, A.R. Assaf, and N.L. Lasser Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
9. E.J. Manson Estrogen plus progestin and risk of coronary heart disease N Engl J Med 349 2003 523 534
10. R.K. Dubey, S. Oparil, B. Imthurn, and E.K. Jackson Sex hormones and hypertension Cardiovasc Res 53 2002 688 708
11. A.M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, and V. Bittner Glycemic effects of postmenopausal hormone therapy: the heart and estrogen/progestin replacement Study. a randomized, double-blind, placebo-controlled trial Ann Intern Med 138 2003 1 9
12. K.L. Margolis, D.E. Bonds, R.J. Rodabough, L. Tinker, L.S. Philllips, and C. Allen Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial Diabetologia 47 2004 1175 1187
13. C. Le May, K. Chu, M. Hu, C.S. Ortega, E.R. Simpson, and K.S. Korach Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice Proc Natl Acad Sci U S A 103 2006 9232 9237
14. M. Cushman, E.N. Meilahn, B.M. Psaty, L.H. Kuller, A.S. Dobs, and R.P. Tracy Hormone replacement therapy, inflammation, hemostasis in elederly women Arterioscler Thromb Vasc Biol 19 1999 893 899
15. J. Miller, B.K. Chan, and H.D. Nelson Postmenopausal estrogen replacement and risk for venous embolism: a systematic review and meta-analysis for the U.S. preventive services task forces Ann Intern Med 136 2002 680 690
16. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Inititative randomized controlled trial JAMA 288 2002 321 333
17. S. Stork, C. von Schacky, and P. Angerer The effect of the 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial Atherosclerosis 165 2002 301 307
18. E. Oger, M. Alhenc-Gelas, K. Lacut, M.T. Blouch, N. Roudaut, and V. Kerlan Differential effects of oral and transdermal estrogen/progesterone regimes on sensitivity to activated protein C among postmenopausal women: a randomized trial Arterioscler Thromb Vasc Biol 23 2003 1671 1676
19. T.B. Clarkson, and S.E. Appt Controversies about HRT- lessons from monkey models Maturitas 51 2005 64 74
20. es Journées nationales, Paris 2008. (Deuxième partie: la ménopause).
21. I. Spyridopoulos, A.B. Sullivan, M. Kearney, J.M. Isner, and D.W. Losordo Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor Circulation 95 1997 1505 1514
22. A. Billon-Gales, C. Fontaine, V. Douin-Echinard, L. Delpy, H. Berges, and B. Calippe Endothelial estrogen receptor a plays a crucial role for the atheroprotective action of estradiol in LDLr deficient mice Circulation 120 2009 2566 2567
23. C.N. Bairey Merz, C. Shufelt, and B.D. Johnson Reproductive hormone exposure timing and ischemic heart disease: complicated answers to a simple question Maturitas 65 2010 297 298
24. F. Grodstein, J.E. Manson, and M.J. Stampfer Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation J Womens Health 15 2006 1
25. J.E. Rossouw, R.L. Prentice, J.E. Manson, L. Wu, D. Barad, and V.M. Barnabei Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297 2007 1465 1477
26. G.M. Sare, L.J. Gray, and P.M. Bath Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis Eur Heart J 29 2008 2031 2041
27. e congrès international sur la ménopause, Buenos Aires, octobre 2005.
28. C. Renoux, S. Dell'Aniello, and S. Suissa Hormone replacement therapy and the risk of venous thromboembolism: a population-based study J Thromb Haemost 8 2010 979 986
29. V. Olié, M. Canonico, and P.Y. Scarabin Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women Curr Opin Hematol 17 2010 457 463
30. C. Renoux, S. Dell'aniello, and E. Garbe Transdermal and oral hormone replacement therapy and the risk of stroke: a nested casecontrol study BMJ 340 2010 c2519
31. Position statement: estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society Menopause. J North Am Menopause Soc 2010;17:242-55.